drugset / Trial / NCT00003878

Carmustine Implants in Treating Patients With Brain Metastases

NCT00003878

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving the drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of implanted carmustine wafers in treating patients who have brain metastases and who are undergoing surgery to remove the tumor.

Timeline

Start
2002-04
Primary completion
Completion
2003-04

Drugs

EvaluationDrugModalityDoseRoute
Subject carmustine Small molecule Other